Total Payments
$3,097
2024 Payments
$985.51
Companies
22
Transactions
79
Medicare Patients
10,076
Medicare Billing
$2.8M
Payment Breakdown by Category
Food & Beverage$1,987 (64.2%)
Consulting$1,110 (35.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,987 | 78 | 64.2% |
| Consulting Fee | $1,110 | 1 | 35.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,110 | 1 | $0 (2019) |
| ABBVIE INC. | $332.14 | 19 | $0 (2024) |
| Allergan, Inc. | $207.50 | 6 | $0 (2020) |
| EyePoint Pharmaceuticals US, Inc. | $157.10 | 1 | $0 (2023) |
| Harrow Eye, LLC | $132.09 | 12 | $0 (2024) |
| Incyte Corporation | $126.81 | 1 | $0 (2021) |
| Alcon Vision LLC | $119.31 | 1 | $0 (2024) |
| Alimera Sciences, Inc. | $114.27 | 7 | $0 (2024) |
| Amgen Inc. | $111.73 | 2 | $0 (2024) |
| Pharmacosmos Therapeutics Inc. | $108.53 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $985.51 | 47 | ABBVIE INC. ($140.90) |
| 2023 | $477.82 | 13 | EyePoint Pharmaceuticals US, Inc. ($157.10) |
| 2022 | $107.14 | 6 | ABBVIE INC. ($78.53) |
| 2021 | $161.62 | 3 | Incyte Corporation ($126.81) |
| 2020 | $161.67 | 3 | Allergan, Inc. ($131.68) |
| 2019 | $1,138 | 3 | PFIZER INC. ($1,110) |
| 2018 | $64.76 | 4 | Allergan Inc. ($47.64) |
All Payment Transactions
79 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: SOLUTION/ DROPS | ||||||
| 12/16/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: OPTOMETRY | ||||||
| 12/13/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: EYE CARE | ||||||
| 12/13/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $2.78 | General |
| Category: EYE CARE | ||||||
| 12/09/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: EYE CARE | ||||||
| 11/15/2024 | Harrow Eye, LLC | IHEEZO (Drug), TRIESENCE | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: OPTOMETRY | ||||||
| 11/12/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: SOLUTION/ DROPS | ||||||
| 10/15/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Ophthalmology | ||||||
| 10/11/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Ophthalmology | ||||||
| 10/07/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: SOLUTION/ DROPS | ||||||
| 10/03/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $119.31 | General |
| Category: Ophthalmology | ||||||
| 09/18/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/16/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: OPTOMETRY | ||||||
| 09/16/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $18.01 | General |
| 09/16/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $0.92 | General |
| Category: OPTOMETRY | ||||||
| 09/13/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: OPTOMETRY | ||||||
| 09/13/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $1.95 | General |
| Category: OPTOMETRY | ||||||
| 09/13/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $1.56 | General |
| Category: OPTOMETRY | ||||||
| 09/09/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: SOLUTION/ DROPS | ||||||
| 08/23/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 08/16/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 08/05/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: EYE CARE | ||||||
| 07/30/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: OPTOMETRY | ||||||
| 07/08/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 2,537 | 5,469 | $2.3M | $784,309 |
| 2022 | 18 | 2,733 | 6,037 | $2.5M | $765,212 |
| 2021 | 17 | 2,635 | 6,086 | $2.3M | $697,042 |
| 2020 | 13 | 2,171 | 4,823 | $1.8M | $532,214 |
Total Patients
10,076
Total Services
22,415
Medicare Billing
$2.8M
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 87 | 649 | $973,500 | $447,932 | 46.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 683 | 1,165 | $203,920 | $117,342 | 57.5% |
| 67028 | Injection of drug into eye | Office | 2023 | 164 | 635 | $412,750 | $60,591 | 14.7% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 281 | 294 | $89,670 | $36,502 | 40.7% |
| 92250 | Photography of the retina | Office | 2023 | 723 | 1,087 | $135,875 | $34,153 | 25.1% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2023 | 12 | 161 | $68,908 | $25,482 | 37.0% |
| 92134 | Imaging of retina | Office | 2023 | 211 | 814 | $203,500 | $18,137 | 8.9% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 84 | 223 | $55,750 | $14,333 | 25.7% |
| 67228 | Destruction of leaking blood vessels of retina using laser | Office | 2023 | 29 | 41 | $104,058 | $11,719 | 11.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 67 | 67 | $14,740 | $8,744 | 59.3% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 72 | 169 | $47,400 | $3,924 | 8.3% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 21 | 41 | $10,250 | $2,311 | 22.6% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 89 | 108 | $4,860 | $2,277 | 46.9% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 14 | 15 | $2,250 | $860.09 | 38.2% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 60 | 528 | $792,000 | $379,343 | 47.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 682 | 1,240 | $217,045 | $124,470 | 57.3% |
| 67028 | Injection of drug into eye | Office | 2022 | 161 | 591 | $384,800 | $56,026 | 14.6% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2022 | 334 | 358 | $109,190 | $40,789 | 37.4% |
| 92250 | Photography of the retina | Office | 2022 | 721 | 1,180 | $147,500 | $36,868 | 25.0% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2022 | 12 | 175 | $74,900 | $27,677 | 37.0% |
| 92134 | Imaging of retina | Office | 2022 | 221 | 1,029 | $257,250 | $18,382 | 7.1% |
| 67228 | Destruction of leaking blood vessels of retina using laser | Office | 2022 | 37 | 64 | $162,432 | $18,167 | 11.2% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2022 | 108 | 301 | $75,250 | $15,699 | 20.9% |
| 67108 | Repair of detached retina with drainage and removal of eye fluid between lens and retina | Facility | 2022 | 15 | 15 | $112,500 | $14,959 | 13.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 84 | 84 | $18,480 | $10,672 | 57.7% |
About Dr. Danielle Strauss, MD
Dr. Danielle Strauss, MD is a Ophthalmology healthcare provider based in Iselin, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2009. The National Provider Identifier (NPI) number assigned to this provider is 1336378736.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Danielle Strauss, MD has received a total of $3,097 in payments from pharmaceutical and medical device companies, with $985.51 received in 2024. These payments were reported across 79 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,987).
As a Medicare-enrolled provider, Strauss has provided services to 10,076 Medicare beneficiaries, totaling 22,415 services with total Medicare billing of $2.8M. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology, Retina Specialist
- Location Iselin, NJ
- Active Since 07/07/2009
- Last Updated 03/30/2017
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1336378736
Products in Payments
- CELEBREX (Drug) $1,110
- OZURDEX (Drug) $222.53
- YUTIQ (Drug) $206.57
- LUMIGAN (Drug) $160.82
- PEMAZYRE (Drug) $126.81
- Clareon (Device) $119.31
- VEVYE (Drug) $115.43
- MONOFERRIC (Drug) $108.53
- OXERVATE (Drug) $97.56
- LUMAKRAS (Drug) $95.07
- XIPERE (Drug) $77.41
- ACTHAR (Biological) $69.96
- DURYSTA (Drug) $62.77
- EYLEA (Biological) $45.18
- XIIDRA (Drug) $43.43
- XDEMVY (Drug) $37.32
- ILUVIEN (Drug) $34.81
- RESTASIS (Drug) $33.09
- Iluvien (Drug) $29.99
- BOTOX THERAPEUTIC (Biological) $28.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Iselin
Douglas Grayson, M.d, M.D
Ophthalmology — Payments: $115,436
Ophthalmology $115,436
Burton Wisotsky, M.d, M.D
Ophthalmology — Payments: $802.88
Ophthalmology $802.88
Dr. Martin Fox, Md, MD
Ophthalmology — Payments: $732.28
Ophthalmology $732.28
James Milite, M.d, M.D
Ophthalmology — Payments: $344.59
Ophthalmology $344.59
Joseph Napolitano, M.d, M.D
Ophthalmology — Payments: $31.02
Ophthalmology $31.02